Osaic Holdings’s Intersect ENT, Inc XENT Stock Holding History

Osaic Holdings’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-574	Closed	-$16K	–	7843
2022 Q1	$16K	Sell	574 -2,647	-82%	-$72.5K	﹤0.01%	5865
2021 Q4	$88K	Sell	3,221 -500	-13%	-$13.6K	﹤0.01%	4692
2021 Q3	$102K	Sell	3,721 -77	-2%	-$1.9K	﹤0.01%	4516
2021 Q2	$65K	Hold	3,798	–	–	﹤0.01%	4845
2021 Q1	$79K	Hold	3,798	–	–	﹤0.01%	4540
2020 Q4	$87K	Sell	3,798 -178	-4%	-$3.39K	﹤0.01%	4157
2020 Q3	$65K	Buy	3,976 +233	+6%	+$4.22K	﹤0.01%	4128
2020 Q2	$51K	Sell	3,743 -226	-6%	-$2.63K	﹤0.01%	4173
2020 Q1	$48K	Buy	+3,969	New	+$88K	﹤0.01%	4007

Osaic Holdings's XENT Position: Q2 2022 in Review

Osaic Holdings sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 574 shares — an estimated $16K sold.

Osaic Holdings first reported a position in XENT in Q1 2020 and held it in 9 quarters. The position peaked at $102K in Q3 2021. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Osaic Holdings reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Osaic Holdings sold 574 Intersect ENT, Inc shares in Q2 2022, an estimated $16K.
Osaic Holdings first reported a position in Intersect ENT, Inc in Q1 2020 and held it in 9 quarters.
Osaic Holdings's Intersect ENT, Inc position peaked at $102K in Q3 2021.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Osaic Holdings's 13F filing for Q2 2022, filed 10 Aug 2022.